Table 1 Cell lines used in the study
Cell lines | Year of deposit | Medium | Tumor | Distributor |
|---|---|---|---|---|
HUH28 | 2004 | RPMI 1640, 10% FCS, Penicillin–Streptomycin | ICC | Cell Bank, Riken BioResources Center, Tsukuba, Japan |
RBE | 1996 | RPMI 1640, 10% FCS, Penicillin–Streptomycin | ICC | Cell Bank, Riken BioResources Center, Tsukuba, Japan |
SSP25 | 1996 | RPMI 1640, 10% FCS, Penicillin–Streptomycin | ICC | Cell Bank, Riken BioResources Center, Tsukuba, Japan |
EGI1 | 1984 | RPMI 1640, 10% FCS, Penicillin–Streptomycin | ECC | DSMZ, Leibniz Institute, Braunschweig, Germany |
CCC5 | 2015 | DMEM, Keratinocyte, 20% FCS, Penicillin–Streptomycin | ECC | DSMZ, Leibniz Institute, Braunschweig, Germany |
TFK1 | 2007 | RPMI 1640, 10% FCS, Penicillin–Streptomycin | ECC | DSMZ, Leibniz Institute, Braunschweig, Germany |
HEP3B | 1976 | RPMI 1640, 10% FCS, Penicillin–Streptomycin | HCC | DSMZ, Leibniz Institute, Braunschweig, Germany |
HUH7 | 1982 | RPMI 1640, 10% FCS, Penicillin–Streptomycin | HCC | Originally from Cell Bank, Riken BioResources Center, Tsukuba, Japan (via Cell lines service GmbH, Eppelheim, Germany) |
HEPG2 | 1975 | RPMI 1640, 10% FCS, Penicillin–Streptomycin | Hepato-blastoma | DSMZ, Leibniz Institute, Braunschweig, Germany |